Morgan Stanley analyst Ravi Shanker maintains Old Dominion Freight Line (NASDAQ:ODFL) with a Equal-Weight and raises the price target from $310 to $340.
Ozempic’s Surging Demand Has Novo Nordisk Restricting It in Europe, Plus An Older Generation Diabetes Drug: What’s Next?
Novo Nordisk A/S (NYSE: NVO) plans to limit starter kit supplies of Ozempic (semaglutide) in Europe and reduce the distribution of Victoza (liraglutide), aiming to bolster Ozempic's production, which has experienced a
